activation central melanocortin pathways fenfluramine
d-fenfluramine d-fen widely prescribed among effective weight loss drugs withdrawn clinical use reports cardiac complications subset patients discerning neurobiology underlying anorexic action d-fen may facilitate development new drugs prevent treat obesity combination functional neuroanatomy feeding electrophysiology studies rodents show d-fen induced anorexia requires activation central nervous system melanocortin pathways results provide mechanistic explanation d-fens anorexic actions indicate drugs targeting downstream melanocortin pathways may prove effective selective anti-obesity treatments
